phenoxybenzamine has been researched along with Atherosclerotic Parkinsonism in 2 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Silvestrini, B | 1 |
| Lisciani, R | 1 |
| O'Keeffe, R | 1 |
| Sharman, DF | 1 |
| Vogt, M | 1 |
2 other studies available for phenoxybenzamine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Experimental data suggesting an adrenergic mechanism in the production of parkinsonian symptoms.
Topics: 5-Hydroxytryptophan; Animals; Atropine; Clonidine; Female; Fenclonine; Imipramine; Male; Mice; Mice, | 1976 |
Effect of drugs used in psychoses on cerebral dopamine metabolism.
Topics: Animals; Atropine; Brain; Butyrophenones; Cats; Chlorpromazine; Dogs; Dopamine; Female; Haloperidol; | 1970 |